CLOROX CO /DE/

CLX 10-Q · Q1 2026

CLX Q1 2026 request

Playground key active
Request URL /api/financials?ticker=CLX&year=2026&quarter=1
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 1,429 1,762 -18.9%
Show Business Segments breakouts
Health and Wellness · Operating Segments 565 698 -19.1%
Household · Operating Segments 362 447 -19.0%
International · Operating Segments 253 259 -2.3%
Lifestyle · Operating Segments 245 320 -23.4%
Show Consolidation Items breakouts
Corporate Non Segment 4 38 -89.5%
Operating Segments 1,425 1,724 -17.3%
Cost of Revenue 833 955 -12.8%
Show Business Segments breakouts
Health and Wellness · Operating Segments 291 322 -9.6%
Household · Operating Segments 246 289 -14.9%
International · Operating Segments 165 158 +4.4%
Lifestyle · Operating Segments 126 157 -19.7%
Gross Profit 596 807 -26.1%
Selling, General & Administrative 277 281 -1.4%
Advertising Expense 166 201 -17.4%
Research & Development 28 31 -9.7%
Interest Expense 23 21 +9.5%
Other Expense Income Net -5 -22 +77.3%
Income Before Taxes 107 177 -39.5%
Income Tax Expense (Benefit) 25 74 -66.2%
Net Income 82 103 -20.4%
Show Equity Components breakouts
Noncontrolling Interest 2 4 -50.0%
Retained Earnings 80 99 -19.2%
Net Income Loss Attributable To Noncontrolling Interest 2 4 -50.0%
Net Income 80 99 -19.2%
EPS (Basic) 0.65 0.8 -18.8%
EPS (Diluted) 0.65 0.8 -18.8%
Wtd Avg Shares (Basic) 122,629 123,795 -0.9%
Wtd Avg Shares (Diluted) 123,018 124,677 -1.3%
Comprehensive Income 72 107 -32.7%
Foreign Currency Transaction Gain Loss Before Tax 1 1 0.0%
Gain Loss On Investments -9 -9 0.0%
Income Loss From Equity Method Investments -1 -2 +50.0%
Show Business Segments breakouts
International · Operating Segments -1 -2 +50.0%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 166
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Money Market Funds 51
Fair Value Inputs Level2 · Bank Time Deposits 14
Receivables Net Current 703 595 +18.2%
Inventory 577
Prepaid Expenses & Other Current Assets 249 109 +128.4%
Total Current Assets 1,695 1,576 +7.6%
Non-Current Assets
Property, Plant & Equipment 1,251 1,242 +0.7%
Operating Lease Right-of-Use Assets 318 341 -6.7%
Goodwill 1,227 1,233 -0.5%
Other Non-Current Assets 476 524 -9.2%
Total Assets 5,528
Show Business Segments breakouts
Health and Wellness · Operating Segments 1,161
Household · Operating Segments 1,060
International · Operating Segments 1,318
Lifestyle · Operating Segments 1,108
Show Consolidation Items breakouts
Corporate Non Segment 881
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 249
Other Assets
Trademarks Net 502 503 -0.2%
Other Intangible Assets Net 59 78 -24.4%
Current Liabilities
Commercial Paper 218
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure 218
Operating Lease Liability Current 89 83 +7.2%
Accounts Payable And Accrued Liabilities Current 1,927 1,472 +30.9%
Total Current Liabilities 2,234 1,579 +41.5%
Non-Current Liabilities
Long-Term Debt 2,485 2,482 +0.1%
Operating Lease Liabilities 286 315 -9.2%
Other Non-Current Liabilities 365 874 -58.2%
Deferred Tax Liabilities 20 23 -13.0%
Total Liabilities 5,390
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 2,703
Long-Term Debt (Q)
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure 2,485
Stockholders' Equity
Common Stock 131 131 0.0%
Additional Paid In Capital Common Stock 1,326 1,297 +2.2%
Retained Earnings 200 31 +545.2%
Treasury Stock Common Value -1,514
Accumulated Other Comprehensive Income -165 -147 -12.2%
Total Stockholders' Equity -22
Minority Interest 160 164 -2.4%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 138 224 -38.4%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -1 -1 0.0%
Accumulated Gain Loss Net Cash Flow Hedge Parent 73 79 -7.6%
Accumulated Other Comprehensive Income -165 -147 -12.2%
Accumulated Translation Adjustment -237 -225 -5.3%
Additional Paid In Capital 1,326 1,297 +2.2%
Common Stock 131 131 0.0%
Noncontrolling Interest 160 164 -2.4%
Retained Earnings 200 31 +545.2%
Treasury Stock Common -1,514 -1,252 -20.9%
Total Liabilities & Equity 5,528 5,497 +0.6%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Depreciation & Amortization 56 54 +3.7%
Show Business Segments breakouts
Health and Wellness · Operating Segments 14 14 0.0%
Household · Operating Segments 21 19 +10.5%
International · Operating Segments 10 10 0.0%
Lifestyle · Operating Segments 7 6 +16.7%
Show Consolidation Items breakouts
Corporate Non Segment 4 5 -20.0%
Stock-Based Compensation 10 13 -23.1%
Show Business Segments breakouts
Health and Wellness · Operating Segments 4 4 0.0%
Household · Operating Segments 3 3 0.0%
International · Operating Segments 1 2 -50.0%
Lifestyle · Operating Segments 2 2 0.0%
Deferred Income Taxes 84 -1 +8500.0%
Other Non-Cash Items -12 -5 -140.0%
Increase Decrease In Receivables 118 84 +40.5%
Change in Inventory -55 -6 -816.7%
Change in Prepaid & Other Assets -41 -38 -7.9%
Increase Decrease In Accounts Payable And Accrued Liabilities -40 -137 +70.8%
Operating Lease Right Of Use Asset And Liability Net -2
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable -107 42 -354.8%
Net Cash from Operations 93 221 -57.9%
Investing Activities
Capital Expenditures -36 -39 +7.7%
Other Investing Activities 2
Net Cash from Investing -34 89 -138.2%
Financing Activities
Proceeds From Repayments Of Short Term Debt 214
Share Repurchases -129 -107 -20.6%
Payments Of Dividends Common Stock -151 -151 0.0%
Issuance Of Common Stock For Employee Stock Plans And Other 7 21 -66.7%
Net Cash from Financing -59 -237 +75.1%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -1 2 -150.0%
Net Change in Cash -1 75 -101.3%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 169 282 -40.1%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key